Skip navigation

Contemporary Solutions for Contract Execution and Financial Management between Research Sites and Trial Sponsors

December 6-8, 2016
  • Philadelphia, PA
SCRS logo

in association with
are proud to present:

CBI logo

The 2nd Annual Clinical Trial Agreements, Investigator Payments and FMV — the only meeting focused on building contemporary solutions for contract executions and financial management between research sites and trial sponsors. This is the go-to event to remain at the forefront of cutting-edge industry initiatives and tackle bottlenecks within the contracting process. With highlighted case studies and methodologies, you will learn to build innovative strategies for improved contract development through execution. This December, hear perspectives from trial sponsors and research sites on specific nuances of contract language, including FMV, site budgets, patient payments, deconstructing the common clauses and more!

Leverage Sponsor-Site Collaborations to Facilitate Efficient Contracts and Improve Trial Timelines:

  • Identify the global legal implications of poorly negotiated and executed contracts
  • Gain in-depth insight on the SCRS and multi-stakeholder initiative
    to create common clauses for CTA’s and its impact current contracting processes
  • Evaluate the Accelerated Clinical Trial Agreements (ACTA) template used by academic sites’ centers of excellence
  • Pull back the curtain between sites, CROs and sponsors and walk through a mock budget negotiation
  • Hear case studies and methodologies for enhanced contract development through execution
  • Assess different strategies for determining FMV between all key stakeholders
  • Hear directly from research sites on concerns, needs and opportunities for collaboration throughout the process
CLE & CPE
Credits Available Pending Approval

About SCRS:
The Society for Clinical Research Sites (SCRS) is a global trade organization representing over 4,000 research sites and 30,000 research professionals in 54 countries. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. For more information visit myscrs.org.

PREVIOUS ATTENDEE ACCLAIM:

There is a clear value in openly discussing the perspectives
of all relevant players in the CTA process. The conference
was truly an insightful experience!

Regional Trial Dictation Specialist, Merck

Understanding each other’s position in relation to the negotiation of a CTA is vital to the end goal of helping the patient. Conferences like this are wonderful to
remind everyone about that.

Manager of Contracts and Grants, Johnson & Johnson

December 6-7, 2016 DoubleTree by Hilton Philadelphia, PA

Clinical Trial Agreements, Investigator Payments and FMV

Contemporary Solutions for Contract Execution and Financial Management between Research Sites and Trial Sponsors

SCRS logo

in association with
are proud to present:

CBI logo

The 2nd Annual Clinical Trial Agreements, Investigator Payments and FMV — the only meeting focused on building contemporary solutions for contract executions and financial management between research sites and trial sponsors. This is the go-to event to remain at the forefront of cutting-edge industry initiatives and tackle bottlenecks within the contracting process. With highlighted case studies and methodologies, you will learn to build innovative strategies for improved contract development through execution. This December, hear perspectives from trial sponsors and research sites on specific nuances of contract language, including FMV, site budgets, patient payments, deconstructing the common clauses and more!

Leverage Sponsor-Site Collaborations to Facilitate Efficient Contracts and Improve Trial Timelines:

  • Identify the global legal implications of poorly negotiated and executed contracts
  • Gain in-depth insight on the SCRS and multi-stakeholder initiative
    to create common clauses for CTA’s and its impact current contracting processes
  • Evaluate the Accelerated Clinical Trial Agreements (ACTA) template used by academic sites’ centers of excellence
  • Pull back the curtain between sites, CROs and sponsors and walk through a mock budget negotiation
  • Hear case studies and methodologies for enhanced contract development through execution
  • Assess different strategies for determining FMV between all key stakeholders
  • Hear directly from research sites on concerns, needs and opportunities for collaboration throughout the process
CLE & CPE
Credits Available Pending Approval

About SCRS:
The Society for Clinical Research Sites (SCRS) is a global trade organization representing over 4,000 research sites and 30,000 research professionals in 54 countries. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. For more information visit myscrs.org.

PREVIOUS ATTENDEE ACCLAIM:

There is a clear value in openly discussing the perspectives
of all relevant players in the CTA process. The conference
was truly an insightful experience!

Regional Trial Dictation Specialist, Merck

Understanding each other’s position in relation to the negotiation of a CTA is vital to the end goal of helping the patient. Conferences like this are wonderful to
remind everyone about that.

Manager of Contracts and Grants, Johnson & Johnson

December 6-7, 2016 DoubleTree by Hilton Philadelphia, PA